Skip to main content

Animations

MJFF Publications

7521 - 7530 of 8816 Results
Title
Year
  • Year
  • 2020
  • 2020
  • 2025
  • 2024
  • 2024
  • 2024
  • 2023
  • 2023
  • 2020
  • 2018
  • Summary Details
    OPEN
    Title: Differential transcript usage unravels transcriptional alterations in Alzheimer's disease human brains
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/alz.038695
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Retracted: Gut Microbiome Signatures of Risk and Prodromal Markers of Parkinson Disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/ana.25788
    Citation Count: 94
  • Summary Details
    OPEN
    Title: Comprehensive characterization of the transcriptional landscape in Alzheimer’s disease (AD) brains
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.adn1927
    Citation Count: 3
  • Summary Details
    OPEN
    Title: KAT8 compound inhibition inhibits the initial steps of PINK1-dependant mitophagy
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-024-60602-9
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Acoustically targeted measurement of transgene expression in the brain
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/sciadv.adj7686
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Experimental capture of miRNA targetomes: disease-specific 3′UTR library-based miRNA targetomics for Parkinson’s disease
    Journal Name: Experimental & Molecular Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s12276-024-01202-5
    Citation Count: 8
  • Summary Details
    RESTRICTED
    Title: Reduction in GABAB on glia induce Alzheimer’s disease related changes
    Journal Name: Brain, Behavior, and Immunity
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.bbi.2023.03.002
    Citation Count: 13
  • Summary Details
    OPEN
    Title: Remuneration and Recruitment of Study Participants for AD Cohort Studies From the General Public and From Minority Communities
    Journal Name: Alzheimer Disease & Associated Disorders
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/wad.0000000000000556
    Citation Count: 2
  • Summary Details
    OPEN
    Title: New 2013 incidence peak in childhood narcolepsy: more than vaccination?
    Journal Name: Sleep
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/sleep/zsaa172
    Citation Count: 21
  • Summary Details
    OPEN
    Title: A similarity-based approach to leverage multi-cohort medical data on the diagnosis and prognosis of Alzheimer's disease
    Journal Name: GigaScience
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1093/gigascience/giy085
    Citation Count: 6
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.